{"id":5172,"date":"2024-06-10T14:12:44","date_gmt":"2024-06-10T06:12:44","guid":{"rendered":"https:\/\/regask.com\/?p=5172"},"modified":"2024-11-05T20:57:03","modified_gmt":"2024-11-05T12:57:03","slug":"aprobada-la-vacuna-contra-el-chikungunya","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/chikungunya-vaccine-approved\/","title":{"rendered":"La EMA recomienda la aprobaci\u00f3n de la primera vacuna que protege\u2026"},"content":{"rendered":"<p>El 31 de mayo de 2024, la Agencia Europea de Medicamentos (EMA) anunci\u00f3 su recomendaci\u00f3n para la aprobaci\u00f3n de Ixchiq, la primera vacuna dise\u00f1ada para proteger a los adultos contra el chikungunya, una enfermedad viral transmitida por mosquitos infectados.<\/p>\n<p>Este avance revolucionario marca un hito importante en la salud p\u00fablica, ya que el chikungunya ha sido una preocupaci\u00f3n creciente debido a su r\u00e1pida propagaci\u00f3n y al intenso dolor articular que provoca. La aprobaci\u00f3n de Ixchiq representa un nuevo hito en los sectores farmac\u00e9utico y sanitario, con el objetivo de combatir la propagaci\u00f3n de esta enfermedad debilitante.<\/p>\n<p><strong>Puntos destacados:<\/strong><\/p>\n<ul>\n<li><strong>P\u00fablico objetivo:<\/strong> La vacuna ha sido autorizada para su uso en adultos, centr\u00e1ndose en un grupo demogr\u00e1fico con riesgo de contraer chikungunya.<\/li>\n<li><strong>Impacto global:<\/strong> Esta aprobaci\u00f3n introduce una medida preventiva vital contra una enfermedad que ha provocado brotes en todo el mundo, destacando el papel fundamental de la vacunaci\u00f3n en el control y la prevenci\u00f3n de enfermedades.<\/li>\n<li><strong>Cumplimiento de la industria:<\/strong> Las empresas involucradas en la producci\u00f3n, distribuci\u00f3n o administraci\u00f3n de vacunas necesitar\u00e1n actualizar sus marcos regulatorios y de cumplimiento para incorporar esta nueva vacuna, asegurando el cumplimiento de las pautas de la EMA.<\/li>\n<li><strong>Orientaci\u00f3n sanitaria:<\/strong> Los proveedores y los equipos reguladores deben mantenerse informados sobre la disponibilidad de la vacuna, el uso recomendado y las posibles actualizaciones de los calendarios de vacunaci\u00f3n.<\/li>\n<li><strong>Monitoreo continuo:<\/strong> Los equipos reguladores tambi\u00e9n deben monitorear m\u00e1s investigaciones o actualizaciones sobre la eficacia y seguridad de la vacuna, ya que los estudios en curso pueden influir en los est\u00e1ndares regulatorios.<\/li>\n<\/ul>\n<p>El dictamen se enviar\u00e1 ahora a la Comisi\u00f3n Europea para que adopte una decisi\u00f3n sobre la autorizaci\u00f3n de comercializaci\u00f3n en toda la UE. El solicitante de Ixchiq es Valneva Austria GmbH.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<a data-animate=\"fadeInLeft\" href=\"https:\/\/www.ema.europa.eu\/en\/news\/first-vaccine-protect-adults-chikungunya\" target=\"_blank\" class=\"button secondary is-link is-medium\" rel=\"noopener\" >\n\t\t<span>Lea el art\u00edculo completo<\/span>\n\t<\/a>\n\n<p>\u00a9Esta alerta de registro es emitida por RegASK<\/p>","protected":false},"excerpt":{"rendered":"<p>On May 31, 2024, the European Medicines Agency (EMA) announced its recommendation for the approval of Ixchiq, the first vaccine designed to protect adults against chikungunya, a viral disease transmitted by infected mosquitoes. This groundbreaking development marks a significant milestone in public health, as chikungunya has been a growing concern due to its rapid spread&#8230;<\/p>","protected":false},"author":39,"featured_media":3960,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[247,419,421,423,425],"class_list":["post-5172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-regulation-eu-legislation","tag-vaccine","tag-chikungunya","tag-ema","tag-market-authorization"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Chikungunya Vaccine Approved by EMA | RegASK<\/title>\n<meta name=\"description\" content=\"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/aprobada-la-vacuna-contra-el-chikungunya\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMA Recommends Approval of the First Vaccine to Protect Adults Against Chikungunya\" \/>\n<meta property=\"og:description\" content=\"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/aprobada-la-vacuna-contra-el-chikungunya\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-10T06:12:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-05T12:57:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya-870x653.png\" \/>\n\t<meta property=\"og:image:width\" content=\"870\" \/>\n\t<meta property=\"og:image:height\" content=\"653\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"EMA Recommends Approval of the First Vaccine to Protect&hellip;\",\"datePublished\":\"2024-06-10T06:12:44+00:00\",\"dateModified\":\"2024-11-05T12:57:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\"},\"wordCount\":282,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"keywords\":[\"Regulation EU Legislation\",\"Vaccine\",\"Chikungunya\",\"EMA\",\"Market Authorization\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\",\"name\":\"Chikungunya Vaccine Approved by EMA | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"datePublished\":\"2024-06-10T06:12:44+00:00\",\"dateModified\":\"2024-11-05T12:57:03+00:00\",\"description\":\"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"width\":1600,\"height\":1200,\"caption\":\"New Vaccine To Protect People In The Eu And Worldwide Against Dengue\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La vacuna contra el chikungunya fue aprobada por la EMA | RegASK","description":"La EMA recomienda la aprobaci\u00f3n de Ixchiq, la primera vacuna que protege a los adultos contra el chikungunya. Conozca m\u00e1s sobre este avance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/aprobada-la-vacuna-contra-el-chikungunya\/","og_locale":"es_ES","og_type":"article","og_title":"EMA Recommends Approval of the First Vaccine to Protect Adults Against Chikungunya","og_description":"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.","og_url":"https:\/\/regask.com\/es\/aprobada-la-vacuna-contra-el-chikungunya\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-06-10T06:12:44+00:00","article_modified_time":"2024-11-05T12:57:03+00:00","og_image":[{"width":870,"height":653,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya-870x653.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#article","isPartOf":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"EMA Recommends Approval of the First Vaccine to Protect&hellip;","datePublished":"2024-06-10T06:12:44+00:00","dateModified":"2024-11-05T12:57:03+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/"},"wordCount":282,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","keywords":["Regulation EU Legislation","Vaccine","Chikungunya","EMA","Market Authorization"],"articleSection":["Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/","url":"https:\/\/regask.com\/chikungunya-vaccine-approved\/","name":"La vacuna contra el chikungunya fue aprobada por la EMA | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","datePublished":"2024-06-10T06:12:44+00:00","dateModified":"2024-11-05T12:57:03+00:00","description":"La EMA recomienda la aprobaci\u00f3n de Ixchiq, la primera vacuna que protege a los adultos contra el chikungunya. Conozca m\u00e1s sobre este avance.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/chikungunya-vaccine-approved\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","width":1600,"height":1200,"caption":"New Vaccine To Protect People In The Eu And Worldwide Against Dengue"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/5172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=5172"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/5172\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/3960"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=5172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=5172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=5172"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}